???global.info.a_carregar???
João Lobo, MD, PhD. João concluded the Master Degree in Medicine in 2013 (Institute of Biomedical Sciences Abel Salazar, University of Porto) and the PhD in Pathology and Molecular Genetics in October 2021 (Institute of Biomedical Sciences Abel Salazar, University of Porto). His PhD Thesis, entitled "Uncovering novel prognostic and predictive epigenetic biomarkers in malignant testicular germ cell tumors" (funded by FCT: SFRH/BD/132751/2017) received in addition the European Doctorate Title. It included 30 publications in international journals. He contributed to the initiation of a new line of investigation at the Cancer Biology and Epigenetics Group of IPO Porto Research Center focused on testicular germ cell tumors. He also actively participated in the EpiMarkGermCell project (funded by FCT: POCI-01-0145-FEDER-29043). João is currently a Pathologist at the Portuguese Oncology Institute of Porto (obtaining board certification in March 2024 with the highest mark in Portugal - 19.95/20). He has been involved in Biobanking activities and in Molecular Pathology and Uropathology fields, with particular attention to the better understanding of testicular germ cell tumors. He is responsible for the implementation of the liquid biopsy IVD CE M371 test at the department of pathology, offered to all testicular cancer patients. He completed a Molecular Pathology internship at the University Medical Center Utrecht (UMCU) and an Uropathology fellowship at the University Hospital Zurich (USZ), under supervision of Prof. Holger Moch, and at the University of Alabama at Birmingham, United States, under supervision of Prof. George Netto and Prof. Cristina Magi-Galluzzi. He is also a Junior Researcher at the Cancer Biology and Epigenetics Group, leading the line of investigation on testicular cancer. João is an Assistant Professor at ICBAS - University of Porto since 2024, lecturing in Pathology (Institute of Biomedical Sciences Abel Salazar, Master Degree in Medicine, University of Porto) and in Biopathology (Faculty of Dental Medicine, Master Degree in Dental Medicine, University of Porto). He also participates regularly as Lecturer in other university curricular units. At age 35, João authored 129 articles in international peer-reviewed journals (61 first author, 6 senior author, h-index 25) and 8 book chapters (all first author). Top impact factors were: 39.3, 24.3 and 14.4. He was author of 81 scientific communications with abstract published in peer-reviewed journals (40 as first author) and peer-reviewed 115 manuscripts. He is Topic Editor of 4 Special Issues in International Journals. João frequently participates in public outreach activities related to his research topics. He supervised 1 and co-supervised 5 Master Thesis Dissertations, and is currently supervisor of 2 PhD Theses and co-supervisor of 1 PhD Thesis. He received several awards throughout his career. Top awards related to his research on testicular germ cell tumors include: 1. ESP Academy Bursary, for top Projects by early career Pathologists, 2018; 2. Tom Voûte Young Investigator Award (2,500 Euro), for the best research project on Pediatric Oncology in the Netherlands, 2019; 3. Award Banco Carregosa / Secção Regional do Norte da Ordem dos Médicos (SRNOM), 4th Edition (2,500 Euro), 2020; 4. MSD Award for Research in Health (10,000 Euro), for the best protocol in medical sciences, 2020; 5. Award Rui Osório de Castro / Millennium BCP (15,000 Euro), for the most innovative research protocol, 2021; 6. Life Young Investigator Award (1,000 CHF) for excellence in the field of life sciences, 2021; 7. Award CUF/Mello (Honorable mention 2023). João is member of several associations related to Urology, Uropathology and Molecular Biology: ESP/SPAP, EAU/YAU Penile and Testis Cancer Group, ESUP (board member), ASPIC (board member), GUPS and MaGIC (Vice-Chair of the Young Investigator Group).
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
João Lobo

Nomes de citação

  • Lobo, João

Identificadores de autor

Ciência ID
8A14-8221-1CBF
ORCID iD
0000-0001-6829-1391

Endereços de correio eletrónico

  • joaomachadolobo@gmail.com (Pessoal)

Telefones

Telemóvel
  • 918950068 (Pessoal)

Moradas

  • Rua da Saudade, 76, 4050-570, Porto, Porto, Portugal (Pessoal)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Patologia
  • Ciências Naturais - Ciências Biológicas - Biologia Molecular

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Português (Idioma materno)
Francês Utilizador independente (B1) Utilizador proficiente (C1) Utilizador independente (B1) Utilizador independente (B1) Utilizador elementar (A1)
Formação
Grau Classificação
2017/10/01 - 2021/10/06
Concluído
 Patologia e Genética Molecular (Doutoramento)
Especialização em Epigenética. Tumores de células germinativas.
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
"UNCOVERING NOVEL PROGNOSTIC AND PREDICTIVE EPIGENETIC BIOMARKERS IN MALIGNANT TESTICULAR GERM CELL TUMORS" (TESE/DISSERTAÇÃO)
2019/01 - 2020/01
Concluído
 PhD Student (Doctor)
Especialização em Testicular germ cell tumors
Prinses Máxima Centrum voor Kinderoncologie, Países Baixos
"Developmental biology and epigenetics as drivers for uncovering relevant germ cell tumor biomarkers" (TESE/DISSERTAÇÃO)
2007 - 2013
Concluído
 Medicina (Mestrado integrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Targeted therapy in metastatic colorectal cancer – state of the art, illustrated with a clinical case" (TESE/DISSERTAÇÃO)
 17,3
2004 - 2007
Concluído
 . (Ensino secundário)
Especialização em Ciência e Tecnologia
Escola Secundária José Macedo Fragateiro, Portugal
 20
2001 - 2004
Concluído
 . (Ensino básico 3º ciclo)
Especialização em 3º ciclo
E.B.2,3 António Dias Simões, Portugal
 20
1999 - 2001
Concluído
 . (Ensino básico 2º ciclo)
Especialização em 2º ciclo
E.B.2,3 António Dias Simões, Portugal
 20
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2024 - Atual Professor Auxiliar Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020/09 - Atual Assistente Convidado (Docente Universitário) Universidade do Porto Faculdade de Medicina Dentária, Portugal
Universidade do Porto Faculdade de Medicina Dentária, Portugal
2016 - Atual Assistente Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2015 - 2023 Médico - Internato de Formação Específica em Anatomia Patológica Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2014/01/01 - 2014/12/31 Médico - Internato de Ano Comum Centro Hospitalar Universitário do Porto EPE, Portugal
Centro Hospitalar Universitário do Porto EPE, Portugal
Projetos

Bolsa

Designação Financiadores
2022 - Atual miREpiTestis: Unveiling miR-371-373 cluster epigenetic reprogramming and downstream targets in testicular germ cell tumors
2022.09566.BD
Orientador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
 Fundação para a Ciência e a Tecnologia
Em curso
2021 - Atual DNA methylation biomarkers as detection and triage tools in population-based cervical cancer screening program
SFRH/BD/143717/2019
CI-IPOP-130-2020-DNAmeCervix
Investigador
Fundação para a Ciência e a Tecnologia
Em curso
2020 - Atual Epitranscriptomic alterations within renal cancer metabolism reprogramming: uncovering new therapeutic targets
DFA/BD/6038/2020
Investigador
Fundação para a Ciência e a Tecnologia
Em curso
2019 - Atual Epigenetic regulation of non-coding RNAs in Prostate Cancer
SFRH/BD/136007/2018
Investigador
Fundação para a Ciência e a Tecnologia
Em curso
2023/03/01 - 2026/02/28 On the crossroads of Immuno-Epigenetics for targeting advanced Prostate Cancer
2022.04809.PTDC
10.54499/2022.04809.PTDC
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2023/03/12 - 2024/09/11 Decoding the role of extracellular vesicles in prostate cancer bone metastasis
2022.05135.PTDC
10.54499/2022.05135.PTDC
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Fundação Champalimaud, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2017/10/01 - 2021/10/01 UNCOVERING NOVEL PROGNOSTIC AND PREDICTIVE EPIGENETIC BIOMARKERS IN MALIGNANT TESTICULAR GERM CELL TUMORS
SFRH/BD/132751/2017
Bolseiro de Doutoramento
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
 Fundação para a Ciência e a Tecnologia
Em curso
2018/01 - 2021/06/30 EpiMarkGermCell-DEVELOPMENT OF NOVEL PROGNOSTIC AND PREDICTIVE EPIGENETIC BIOMARKERS FOR MALIGNANT TESTICULAR GERM CELL TUMORS
POCI-01-0145-FEDER-29043
PTDC/MEC-URO/29043/2017
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2017 - 2021 Loss of proteostasis in cancer: alterations in steroid hormone receptor function leading to endocrine therapy resistance
SFRH/BD/123821/2016
Investigador
Fundação para a Ciência e a Tecnologia
Concluído
2017 - 2020 Unraveling the interactome of phosphoprotein phosphatase 1: searching for biomarkers and putative therapeutic target for human prostate cancer
SFRH/BD/102981/2014
Investigador
Fundação para a Ciência e a Tecnologia
Concluído
2015 - 2020 Role of VIM in Epithelial Mesenchymal Transition (EMT) in urothelial cancer
SFRH/BD/112673/2015
Investigador
Fundação para a Ciência e a Tecnologia
Concluído
2017 - 2018 Metastatic breast cancer: finding molecular biomarkers in liquid biopsies
.
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Concluído

Projeto

Designação Financiadores
2021 - Atual Promoter methylation of DNA repair genes as biomarker of response to platin-based chemotherapy: a pan-cancer investigation
PlatiMethylPredict
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Em curso
2021 - Atual Cyclic loading effects in bladder cancer cells
PTDC/EMEAPL/ 1342/2020
Investigador
Fundação para a Ciência e a Tecnologia
Em curso
2019 - Atual Early-stage cancer treatment, driven by context of molecular imaging (ESTIMA) Project
NORTE-01-0145-FEDER-000027
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2019 - Atual MCTKidCan: Monocarboxylate Transporters (MCTs) in kidney cancer: the role of epigenetic mechanisms
MCTKidCan
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Concluído
2018 - Atual HyTherCaP: Hydralazine - Testing an off-label effect in Castration-Resistant Prostate Cancer
PTDC/MEC-ONC/29030/2017
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
 Fundação para a Ciência e a Tecnologia
Concluído
2021/03/01 - 2024/02/29 CyclicCell - Cyclic loading effects in bladder cancer cells
PTDC/EME-APL/1342/2020
Associated Laboratory for Energy Transports and Aeronautics, Portugal

Instituto de Ciência e Inovação em Engenharia Mecânica e Engenharia Industrial, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2017/10 - 2021/10 EpiMarkGermCell
POCI-01-0145-FEDER-29043
SFRH/BD/132751/2017
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
 Fundação para a Ciência e a Tecnologia
Em curso
2016 - 2017 Epigenetic Profiling as a tool for Testicular Germ Cell Tumors Subtyping
.
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Concluído
2016 - 2017 miR-371a-3p as a tool for subtyping testicular germ cell tumors
.
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Concluído

Outro

Designação Financiadores
2024 - Atual A Importância do registo macroscópico em Anatomia Patológica: desenvolvimento de protocolos de atuação tendo em vista o benefício do doente e dos serviços hospitalares
TC_32
Orientador
2019 - Atual Immunoprofiling characterisation of clinical samples by IHC and gene expression analysis and correlation with clinical outcomes in support of translational medicine strategies for ICOS and PD-L1-IC antibody therapeutics
KYMAB_IPOPORTO_01
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Em curso
2017 - Atual Double-hit lymphoma
GILEAD
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2017 - 2019 E-cadherin (clone 36) nuclear staining in Breast Cancer and comparison with alternative clone staining and P-cadherin staining
DIAGNOSTIC STUDY PROTOCOL D110204
Investigador
Produções

Publicações

Artigo em revista
  1. João Lobo; Bassel Zein-Sabatto; Priti Lal; George J. Netto. "Digital and Computational Pathology Applications in Bladder Cancer: Novel Tools Addressing Clinically Pressing Needs". Modern Pathology (2025): https://doi.org/10.1016/j.modpat.2024.100631.
    10.1016/j.modpat.2024.100631
  2. Andres M Acosta; Daniel M Berney; João Lobo; Muhammad T Idrees; Thomas M Ulbright. "Proposal for a reappraisal of the current classification of so-called “somatic-type” malignancies arising in germ cell tumours". Histopathology (2024): https://doi.org/10.1111/his.15288.
    10.1111/his.15288
  3. Rita Carvalho; Liliana Santos; Inês Conde; Ricardo Leitão; Hugo RS Ferreira; Célia Gomes; Ana Paula Silva; et al. "Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain". The Journal of Pathology (2024): https://doi.org/10.1002/path.6319.
    10.1002/path.6319
  4. Sofia Salta; José Pedro Sequeira; João Lobo; Ana Sousa; Hugo Sousa; Inês Baldaque; Paula Monteiro; et al. "Preliminary outcomes of the Cervical Cancer Screening Program of Northern Portugal: A snapshot". Journal of Infection and Public Health (2024): https://doi.org/10.1016/j.jiph.2024.04.020.
    10.1016/j.jiph.2024.04.020
  5. João Lobo; Nuno Tiago Tavares; Carmen Jerónimo; Rui Henrique; Eugenia Dvindenko; Kristine M. Cornejo; Daniel M. Berney; et al. "Analysis of MicroRNA-371-373 supports that a subset of spermatocytic tumors demonstrates biologic features similar to those of GCNIS-derived germ cell tumors". Human Pathology (2024): https://doi.org/10.1016/j.humpath.2024.05.005.
    10.1016/j.humpath.2024.05.005
  6. João Lobo; Sofia Canete-Portillo; Maria Del Carmen Rodriguez Pena; Jesse K. McKenney; Manju Aron; Felipe Massicano; Brandon M. Wilk; et al. "Molecular Characterization of Juxtaglomerular Cell Tumors: Evidence of Alterations in MAPK–RAS Pathway". Modern Pathology (2024): https://doi.org/10.1016/j.modpat.2024.100492.
    10.1016/j.modpat.2024.100492
  7. Estevão-Pereira, Helena; Guimarães-Teixeira, Catarina; Flores, Bianca C. T.; Moreira-Silva, Filipa; Tavares, Nuno Tiago; Guimarães, Rita; Braga, Isaac; et al. "EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors". Andrology (2024): http://dx.doi.org/10.1111/andr.13604.
    10.1111/andr.13604
  8. João Lobo; Nazario P Tenace; Sofia Cañete-Portillo; Isa Carneiro; Rui Henrique; Roberta Lucianò; Lara R Harik; Cristina Magi-Galluzzi. "Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall". Histopathology (2024): https://doi.org/10.1111/his.15094.
    10.1111/his.15094
  9. João Lobo; Paula Lopes; Rui Henrique; Ângelo Rodrigues. "The enigmatic occurrence of Pacinian corpuscles in the prostate gland: Report of a case with pericorpuscular and intracorpuscular growth of prostatic acinar adenocarcinoma". Pathology International (2023): https://doi.org/10.1111/pin.13392.
    10.1111/pin.13392
  10. João Lobo; Lara R Harik; Charles C Peyton; Mariana Andozia Morini; Bassel Zein-Sabatto; Thomas Winokur; Valeria Dal Zotto; Cristina Magi-Galluzzi. "Solitary fibrous tumours involving the genitourinary tract: a case series in rare locations, highlighting the role of STAT6 immunohistochemistry". Virchows Archiv (2023): https://doi.org/10.1007/s00428-023-03694-4.
    10.1007/s00428-023-03694-4
  11. Tavares, Nuno Tiago; Lobo, João; Bagrodia, Aditya. "MicroRNAs for detecting occult genitourinary cancer". Current Opinion in Urology 34 1 (2023): 20-26. http://dx.doi.org/10.1097/mou.0000000000001137.
    10.1097/mou.0000000000001137
  12. João Lobo; Andres M. Acosta; George J. Netto. "Molecular Biomarkers With Potential Clinical Application in Testicular Cancer". Modern Pathology (2023): https://doi.org/10.1016/j.modpat.2023.100307.
    10.1016/j.modpat.2023.100307
  13. Jan Niklas Mink; Oybek Khalmurzaev; Alexey Pryalukhin; Carol Immanuel Geppert; Stefan Lohse; Kristof Bende; João Lobo; et al. "Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas". Cancers (2023): https://doi.org/10.3390/cancers15194748.
    10.3390/cancers15194748
  14. João Lobo; Mariana A Morini; Bassel Zein-Sabatto; Shuko Harada; Cristina Magi-Galluzzi. "De-differentiated liposarcomas with solitary fibrous tumour-like pattern and STAT6 nuclear expression: an important diagnostic pitfall". Histopathology (2023): https://doi.org/10.1111/his.14995.
    10.1111/his.14995
  15. Salta, Sofia; Lobo, João; Magalhães, Bruno; Henrique, Rui; Jerónimo, Carmen. Autor correspondente: Jerónimo, Carmen. "DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis". Clinical Epigenetics 15 1 (2023): http://dx.doi.org/10.1186/s13148-023-01537-2.
    Publicado • 10.1186/s13148-023-01537-2
  16. João Lobo; Nuno Tiago Tavares; Daniela Barros-Silva; Alina Rosinha; António Morais; Carmen Jerónimo; Ângelo Rodrigues; Rui Henrique. "MiR-371a-3p in cystic trophoblastic tumour of the testis: supporting a maturation phenomenon towards teratoma". Histopathology (2023): https://doi.org/10.1111/his.14929.
    10.1111/his.14929
  17. Nuno Tiago Tavares; Rui Henrique; Aditya Bagrodia; Carmen Jerónimo; João Lobo. "A stroll through the present and future of testicular germ cell tumour biomarkers". Expert Review of Molecular Diagnostics (2023): https://doi.org/10.1080/14737159.2023.2206956.
    10.1080/14737159.2023.2206956
  18. Vera Constâncio; Nuno Tiago Tavares; Rui Henrique; Carmen Jerónimo; João Lobo. "MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?". Andrology (2023): https://doi.org/10.1111/andr.13258.
    10.1111/andr.13258
  19. Francisco Conceição; Daniela M. Sousa; Sofia Tojal; Catarina Lourenço; Carina Carvalho-Maia; Helena Estevão-Pereira; João Lobo; et al. "The Secretome of Parental and Bone Metastatic Breast Cancer Elicits Distinct Effects in Human Osteoclast Activity after Activation of ß2 Adrenergic Signaling". Biomolecules (2023): https://doi.org/10.3390/biom13040622.
    10.3390/biom13040622
  20. Nuno Tiago Tavares; Rui Henrique; Carmen Jerónimo; João Lobo. "Targeting histone deacetylases in testicular germ cell tumours: an encouraging treatment approach for the future†". The Journal of Pathology (2023): https://doi.org/10.1002/path.6037.
    10.1002/path.6037
  21. Jan Roška; João Lobo; Danica Ivovic; Lenka Wachsmannová; Thomas Mueller; Rui Henrique; Carmen Jerónimo; Miroslav Chovanec; Dana Jurkovicová. "Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms24032495.
    10.3390/ijms24032495
  22. Macedo-Silva, Catarina; Constâncio, Vera; Miranda-Gonçalves, Vera; Leite-Silva, Pedro; Salta, Sofia; Lobo, João; Guimarães, Rita; et al. "DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation". Cancer Medicine 12 7 (2023): 8777-8788. http://dx.doi.org/10.1002/cam4.5623.
    10.1002/cam4.5623
  23. Sara Monteiro-Reis; João P. S. Ferreira; Ricardo A. Pires; João Lobo; João A. Carvalho; Rui L. Reis; Renato Natal Jorge; Carmen Jerónimo. "Bladder Wall Stiffness after Cystectomy in Bladder Cancer Patients: A Preliminary Study". Cancers (2023): https://doi.org/10.3390/cancers15020359.
    10.3390/cancers15020359
  24. Monteiro-Reis, Sara; Miranda-Gonçalves, Vera; Guimarães-Teixeira, Catarina; Martins-Lima, Cláudia; Lobo, João; Montezuma, Diana; Dias, Paula C.; et al. "Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition". International Journal of Biological Sciences 19 1 (2023): 1-12. http://dx.doi.org/10.7150/ijbs.77181.
    Publicado • 10.7150/ijbs.77181
  25. João Lobo; João Gama; Rita Luis; Dina Tiniakos; Maria Augusta Cipriano. "Hepatic Progenitor Cells in the Form of Ductular Structures within a GIST Liver Metastasis: Supporting a Putative Role in the Hepatic Metastatic Niche". Pathobiology (2023): https://doi.org/10.1159/000531456.
    10.1159/000531456
  26. João Lobo; Cláudia Lobo; Luís Leça; Ângelo Rodrigues; Rui Henrique; Paula Monteiro. "Evaluation of the Implementation and Diagnostic Accuracy of the Paris Classification for Reporting Urinary Cytology in Voided Urine Specimens: A Cyto-Histological Correlation Study in a Cancer Center". Pathobiology (2023): https://doi.org/10.1159/000527980.
    10.1159/000527980
  27. Inês Direito; Daniela Gomes; Fátima Liliana Monteiro; Isa Carneiro; João Lobo; Rui Henrique; Carmen Jerónimo; Luisa Alejandra Helguero. "The Clinicopathological Significance of BiP/GRP-78 in Breast Cancer: A Meta-Analysis of Public Datasets and Immunohistochemical Detection". Current Oncology (2022): https://doi.org/10.3390/curroncol29120710.
    10.3390/curroncol29120710
  28. Daniela M. Sousa; Veronica Fernandes; Catarina Lourenço; Carina Carvalho-Maia; Helena Estevão-Pereira; João Lobo; Mariana Cantante; et al. "Profiling the Adrenergic System in Breast Cancer and the Development of Metastasis". Cancers (2022): https://doi.org/10.3390/cancers14225518.
    10.3390/cancers14225518
  29. Adriana Fonseca; João Lobo; Florette K. Hazard; Joanna Gell; Peter K. Nicholls; Robert S. Weiss; Lindsay Klosterkemper; et al. "Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium". British Journal of Cancer (2022): https://doi.org/10.1038/s41416-022-02000-4.
    10.1038/s41416-022-02000-4
  30. Outeiro-Pinho, Gonçalo; Barros-Silva, Daniela; Moreira-Silva, Filipa; Lobo, João; Carneiro, Isa; Morais, António; Martins, Eduarda P; et al. "Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness". Translational Research 249 (2022): 110-127. https://www.translationalres.com/article/S1931-5244(22)00141-4/fulltext.
    Publicado
  31. João Lobo; Riuko Ohashi; Mahul B Amin; Daniel M Berney; Eva M Compérat; Ian A Cree; Anthony J Gill; et al. "WHO 2022 landscape of papillary and chromophobe renal cell carcinoma". Histopathology (2022): https://doi.org/10.1111/his.14700.
    10.1111/his.14700
  32. Juliana Felgueiras; João Lobo; Vânia Camilo; Isa Carneiro; Bárbara Matos; Rui Henrique; Carmen Jerónimo; Margarida Fardilha. "PP1 catalytic isoforms are differentially expressed and regulated in human prostate cancer". Experimental Cell Research (2022): https://doi.org/10.1016/j.yexcr.2022.113282.
    10.1016/j.yexcr.2022.113282
  33. João Lobo; Markus Rechsteiner; Birgit M Helmchen; Niels J Rupp; Achim Weber; Holger Moch. "Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study". Histopathology (2022): https://doi.org/10.1111/his.14663.
    10.1111/his.14663
  34. João Lobo; Ângelo Rodrigues; Rui Henrique; Ailsa Christiansen; Jörg Beyer; Holger Moch; Peter Karl Bode. "Morphological spectrum and molecular features of somatic malignant transformation in germ cell tumours". Histopathology (2022): https://doi.org/10.1111/his.14667.
    10.1111/his.14667
  35. Nuno Tiago Tavares; Saule Gumauskaite; João Lobo; Carmen Jerónimo; Rui Henrique. "DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?". Cancers 14 12 (2022): 2918-2918. https://doi.org/10.3390/cancers14122918.
    10.3390/cancers14122918
  36. Sequeira, José Pedro; Lobo, João; Constâncio, Vera; Brito-Rocha, Tiago; Carvalho-Maia, Carina; Braga, Isaac; Maurício, Joaquina; Henrique, Rui; Jerónimo, Carmen. "DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients". Frontiers in Oncology 12 (2022): http://dx.doi.org/10.3389/fonc.2022.876732.
    10.3389/fonc.2022.876732
  37. Moreira-Silva, Filipa; Outeiro-Pinho, Gonçalo; Lobo, João; Guimarães, Rita; Gaspar, Vítor M.; Mano, João F.; Agirre, Xabier; et al. "G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models". Biomedicine & Pharmacotherapy 150 (2022): 113031. http://dx.doi.org/10.1016/j.biopha.2022.113031.
    10.1016/j.biopha.2022.113031
  38. José Pedro Sequeira; Vera Constâncio; Sofia Salta; João Lobo; Daniela Barros-Silva; Carina Carvalho-Maia; Jéssica Rodrigues; et al. "LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma". Cancers (2022): https://doi.org/10.3390/cancers14040858.
    10.3390/cancers14040858
  39. Beatriz Chaves Lourenço; Catarina Guimarães-Teixeira; Bianca Troncarelli Flores; Vera Miranda-Gonçalves; Rita Guimarães; Mariana Cantante; Paula Lopes; et al. "Ki67 and LSD1 Expression in Testicular Germ Cell Tumors Is Not Associated with Patient Outcome: Investigation Using a Digital Pathology Algorithm". Life (2022): https://www.mdpi.com/2075-1729/12/2/264.
    10.3390/life12020264
  40. Cláudia Martins-Lima; Vera Miranda-Gonçalves; João Lobo; Vera Constâncio; Pedro Leite-Silva; Catarina Guimarães-Teixeira; Sara Monteiro-Reis; et al. "Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression". Cellular Oncology (2022): https://doi.org/10.1007/s13402-021-00657-2.
    10.1007/s13402-021-00657-2
  41. Catarina Guimarães-Teixeira; João Lobo; Vera Miranda-Gonçalves; Daniela Barros-Silva; Cláudia Martins-Lima; Sara Monteiro-Reis; José Pedro Sequeira; et al. "Downregulation of m 6 A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness". Molecular Oncology (2022): https://doi.org/10.1002/1878-0261.13181.
    10.1002/1878-0261.13181
  42. Nicole Viveiros; Bianca CT Flores; João Lobo; Cláudia Martins-Lima; Mariana Cantante; Paula Lopes; Cecilia Deantonio; et al. "Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies". Clinical & Translational Immunology (2022): https://doi.org/10.1002/cti2.1402.
    10.1002/cti2.1402
  43. Sara Petronilho; José Pedro Sequeira; Sofia Paulino; Paula Lopes; Susana Lisboa; Sérgio Chacim; João Lobo; et al. "Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma". Journal of Personalized Medicine (2021): https://doi.org/10.3390/jpm11121384.
    10.3390/jpm11121384
  44. Vera Miranda-Gonçalves; João Lobo; Catarina Guimarães-Teixeira; Daniela Barros-Silva; Rita Guimarães; Mariana Cantante; Isaac Braga; et al. "The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors". Journal of Experimental & Clinical Cancer Research (2021): https://doi.org/10.1186/s13046-021-02072-9.
    10.1186/s13046-021-02072-9
  45. João Lobo; Vera Constâncio; Pedro Leite-Silva; Rita Guimarães; Mariana Cantante; Isaac Braga; Joaquina Maurício; et al. "Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples". Clinical Epigenetics (2021): https://doi.org/10.1186/s13148-021-01048-y.
    10.1186/s13148-021-01048-y
  46. João Lobo; Carmen Jerónimo; Rui Henrique. "Morphological and molecular heterogeneity in testicular germ cell tumors: implications for dedicated investigations". Virchows Archiv (2021): https://doi.org/10.1007/s00428-021-03194-3.
    10.1007/s00428-021-03194-3
  47. José Pedro Sequeira; Vera Constâncio; João Lobo; Rui Henrique; Carmen Jerónimo. "Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma". Cancers 13 21 (2021): 5252-5252. https://doi.org/10.3390/cancers13215252.
    10.3390/cancers13215252
  48. João Lobo; Lieke M. J. van Zogchel; Mohammed G. Nuru; Ad J. M. Gillis; C. Ellen van der Schoot; Godelieve A. M. Tytgat; Leendert H. J. Looijenga. "Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients". Cancers 13 20 (2021): 5228-5228. https://doi.org/10.3390/cancers13205228.
    10.3390/cancers13205228
  49. João Lobo; Riuko Ohashi; Birgit M. Helmchen; Niels J. Rupp; Jan H. Rüschoff; Holger Moch. "The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth". Biomedicines 9 10 (2021): 1418-1418. https://doi.org/10.3390/biomedicines9101418.
    10.3390/biomedicines9101418
  50. Guimarães-Teixeira, Catarina; Barros-Silva, Daniela; Lobo, João; Soares-Fernandes, Diana; Constâncio, Vera; Leite-Silva, Pedro; Silva-Santos, Rui; et al. "Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes". Journal of Personalized Medicine 11 10 (2021): 996. http://dx.doi.org/10.3390/jpm11100996.
    10.3390/jpm11100996
  51. Inês Direito; Liliana Monteiro; Tânia Melo; Daniela Figueira; João Lobo; Vera Enes; Gabriela Moura; et al. "Protein Aggregation Patterns Inform about Breast Cancer Response to Antiestrogens and Reveal the RNA Ligase RTCB as Mediator of Acquired Tamoxifen Resistance". Cancers 13 13 (2021): 3195-3195. https://doi.org/10.3390/cancers13133195.
    10.3390/cancers13133195
  52. Lobo, João. "Re: Lucia Nappi, Marisa Thi, Nabil Adra, et al. Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors. Eur Urol 2021;79:16-9.". European urology (2021): https://doi.org/10.1016/j.eururo.2021.03.032.
    10.1016/j.eururo.2021.03.032
  53. João Lobo; Ricardo Leão; Carmen Jerónimo; Rui Henrique. "Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions". International Journal of Molecular Sciences 22 5 (2021): 2654-2654. https://doi.org/10.3390/ijms22052654.
    10.3390/ijms22052654
  54. João Lobo; Vera Constâncio; Catarina Guimarães-Teixeira; Pedro Leite-Silva; Vera Miranda-Gonçalves; José Pedro Sequeira; Laura Pistoni; et al. "Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors". Molecular Oncology (2021): https://doi.org/10.1002/1878-0261.12909.
    10.1002/1878-0261.12909
  55. João Lobo; Ana Rita Cardoso; Vera Miranda-Gonçalves; Leendert H. J. Looijenga; Marie Lopez; Paola B. Arimondo; Rui Henrique; Carmen Jerónimo. "Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest". Pharmaceutics (2021): https://doi.org/10.3390/pharmaceutics13010073.
    10.3390/pharmaceutics13010073
  56. Lobo, João. "Targeted Methylation Analyses: From Bisulfite Treatment to Quantification.". Methods in molecular biology (Clifton, N.J.) (2021): https://doi.org/10.1007/978-1-0716-0860-9_12.
    10.1007/978-1-0716-0860-9_12
  57. Lobo, João. "JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.". Cell death & disease (2020): https://europepmc.org/articles/PMC7736883.
    10.1038/s41419-020-03279-y
  58. Lobo, João. "Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer". European Urology Oncology (2020): http://dx.doi.org/10.1016/j.euo.2020.11.004.
    10.1016/j.euo.2020.11.004
  59. João Lobo; Ad J. M. Gillis; Annette van den Berg; Leendert H. J. Looijenga. "Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers". BMC Cancer 20 1 (2020): https://doi.org/10.1186/s12885-020-07220-6.
    10.1186/s12885-020-07220-6
  60. Lobo, João. "Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression". Journal of Translational Medicine (2020): http://dx.doi.org/10.1186/s12967-020-02475-w.
    10.1186/s12967-020-02475-w
  61. "Combining hypermethylated RASSF1A detection using droplet digital PCR with miR-371a-3p testing: an improved and highly sensitive panel of liquid biopsy biomarkers for testicular germ cell tumour patients. Oral communication.". Virchows Archiv 477 S1 (2020): 1-390. http://dx.doi.org/10.1007/s00428-020-02938-x.
    10.1007/s00428-020-02938-x
  62. João Lobo; Catarina Guimarães-Teixeira; Daniela Barros-Silva; Vera Miranda-Gonçalves; Vânia Camilo; Rita Guimarães; Mariana Cantante; et al. "Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors". Cancers (2020): https://doi.org/10.3390/cancers12102903.
    10.3390/cancers12102903
  63. João Lobo; Maria Ana Alzamora; Rita Guimarães; Mariana Cantante; Paula Lopes; Isaac Braga; Joaquina Maurício; Carmen Jerónimo; Rui Henrique. "p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome". Andrology 8 5 (2020): 1233-1242. https://doi.org/10.1111/andr.12814.
    10.1111/andr.12814
  64. João Lobo; Rita Guimarães; Vera Miranda-Gonçalves; Sara Monteiro-Reis; Mariana Cantante; Luís Antunes; Isaac Braga; et al. "Differential expression of DNA methyltransferases and demethylases among the various testicular germ cell tumor subtypes". Epigenomics (2020): https://doi.org/10.2217/epi-2020-0066.
    10.2217/epi-2020-0066
  65. Lobo, João. "Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study.". Advances in anatomic pathology (2020): https://doi.org/10.1097/PAP.0000000000000268.
    10.1097/pap.0000000000000268
  66. Lobo, João. "Clinical implications of the American Joint Committee on Cancer (AJCC) 8th edition update in seminoma pT1 subclassification.". BMC urology (2020): https://europepmc.org/articles/PMC7439661.
    10.1186/s12894-020-00682-7
  67. Ana Rita Cardoso; João Lobo; Vera Miranda-Gonçalves; Rui Henrique; Carmen Jerónimo. "Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of ‘epidrugs’". Epigenetics (2020): https://doi.org/10.1080/15592294.2020.1805682.
    10.1080/15592294.2020.1805682
  68. Francisca Dias; Ana Luísa Teixeira; Inês Nogueira; Mariana Morais; Joana Maia; Cristian Bodo; Marta Ferreira; et al. "Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot Study". International Journal of Molecular Sciences 21 13 (2020): 4624-4624. https://doi.org/10.3390/ijms21134624.
    10.3390/ijms21134624
  69. João Lobo; Carmen Jerónimo; Rui Henrique. "Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives". Cancers (2020): https://doi.org/10.3390/cancers12061601.
    10.3390/cancers12061601
  70. Francisca Dias; Ana Luísa Teixeira; Inês Nogueira; Mariana Morais; Joana Maia; Cristian Bodo; Marta Ferreira; et al. "Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease". Cancers (2020): https://doi.org/10.3390/cancers12061450.
    10.3390/cancers12061450
  71. Lobo, João. "Random biopsies in patients harboring a CDH1 mutation: time to change the approach?". Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2020): https://doi.org/10.17235/reed.2020.6720/2019.
    10.17235/reed.2020.6720/2019
  72. Vera Miranda-Gonçalves; Ana Lameirinhas; Catarina Macedo-Silva; João Lobo; Paula C. Dias; Verónica Ferreira; Rui Henrique; Carmen Jerónimo. "Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation". Cells 9 4 (2020): 1053-1053. https://doi.org/10.3390/cells9041053.
    10.3390/cells9041053
  73. Inês Maria Guerreiro; Daniela Barros-Silva; Paula Lopes; Mariana Cantante; Ana Luísa Cunha; João Lobo; Luís Antunes; et al. "RAD51Bme Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer". Journal of Clinical Medicine 9 4 (2020): 1000-1000. https://doi.org/10.3390/jcm9041000.
    10.3390/jcm9041000
  74. Lobo, João. "The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy". Urologic Oncology: Seminars and Original Investigations (2020): http://dx.doi.org/10.1016/j.urolonc.2020.03.004.
    10.1016/j.urolonc.2020.03.004
  75. Lobo, João. "VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer". Cancers (2020): http://dx.doi.org/10.3390/cancers12040771.
    10.3390/cancers12040771
  76. Lobo, João. "CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males". Cancers (2020): http://dx.doi.org/10.3390/cancers12030760.
    10.3390/cancers12030760
  77. Kristian Almstrup; João Lobo; Nina Mørup; Gazanfer Belge; Ewa Rajpert-De Meyts; Leendert H. J. Looijenga; Klaus-Peter Dieckmann. "Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours". Nature Reviews Urology (2020): https://doi.org/10.1038/s41585-020-0296-x.
    10.1038/s41585-020-0296-x
  78. Lobo, João. "Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence.". Molecular medicine (Cambridge, Mass.) (2020): https://doi.org/10.1186/s10020-020-0147-5.
    10.1186/s10020-020-0147-5
  79. João Lobo; Carmen Jerónimo; Rui Henrique. "Targeting the Immune system and Epigenetic Landscape of Urological Tumors". International Journal of Molecular Sciences 21 3 (2020): 829-829. https://doi.org/10.3390/ijms21030829.
    10.3390/ijms21030829
  80. João Lobo; Ad J.M. Gillis; Annette van den Berg; Lambert C.J. Dorssers; Gafanzer Belge; Klaus-Peter Dieckmann; Henk P. Roest; et al. "Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data". Cells (2019): https://doi.org/10.3390/cells8121637.
    10.3390/cells8121637
  81. Lobo, João. "Canine ovarian gonadoblastoma with dysgerminoma overgrowth: a case study and literature review". Journal of Ovarian Research (2019): http://dx.doi.org/10.1186/s13048-019-0561-x.
    10.1186/s13048-019-0561-x
  82. João Lobo; Ana Laura Costa; Mariana Cantante; Rita Guimarães; Paula Lopes; Luís Antunes; Isaac Braga; et al. "m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance". Journal of Translational Medicine (2019): https://doi.org/10.1186/s12967-019-1837-z.
    10.1186/s12967-019-1837-z
  83. Lobo, João. "Overexpression of circulating MiR-30b-5p identifies advanced breast cancer". Journal of Translational Medicine (2019): http://dx.doi.org/10.1186/s12967-019-02193-y.
    10.1186/s12967-019-02193-y
  84. João Lobo; Ângelo Rodrigues; Rita Guimarães; Mariana Cantante; Paula Lopes; Joaquina Maurício; Jorge Oliveira; Carmen Jerónimo; Rui Henrique. "Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers". Cancers (2019): https://doi.org/10.3390/cancers11101535.
    10.3390/cancers11101535
  85. Lobo, João. "XIST-Promoter Demethylation as Tissue Biomarker for Testicular Germ Cell Tumors and Spermatogenesis Quality". Cancers (2019): http://dx.doi.org/10.3390/cancers11091385.
    10.3390/cancers11091385
  86. Lobo, João. "Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer". Frontiers in Genetics (2019): http://dx.doi.org/10.3389/fgene.2019.00815.
    10.3389/fgene.2019.00815
  87. Lobo, João. "Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas". The American Journal of Surgical Pathology (2019): http://dx.doi.org/10.1097/pas.0000000000001352.
    10.1097/pas.0000000000001352
  88. Lobo, João. "Widening the spectrum of Lynch syndrome: first report of testicular seminoma attributable to MSH2 loss". Histopathology (2019): http://dx.doi.org/10.1111/his.13979.
    10.1111/his.13979
  89. Lobo, João. "E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients". Modern Pathology (2019): http://dx.doi.org/10.1038/s41379-019-0294-9.
    10.1038/s41379-019-0294-9
  90. Cátia Iracema Morais; João Lobo; João P. Barreto; Cláudia Lobo; Nuno D. Gonçalves. "Neuroendocrine differentiation of prostatic adenocarcinoma – an important cause for castration-resistant disease recurrence". LaboratoriumsMedizin 0 0 (2019): https://doi.org/10.1515%2Flabmed-2018-0190.
    10.1515/labmed-2018-0190
  91. João Lobo; Ad Gillis; Carmen Jerónimo; Rui Henrique; Leendert Looijenga. "Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic". International Journal of Molecular Sciences 20 2 (2019): 258-258. https://doi.org/10.3390%2Fijms20020258.
    10.3390/ijms20020258
  92. Sara Monteiro-Reis; João Lobo; Rui Henrique; Carmen Jerónimo. "Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer". International Journal of Molecular Sciences 20 2 (2019): 297-297. https://doi.org/10.3390%2Fijms20020297.
    10.3390/ijms20020297
  93. Lobo, João. "Expression of EMT-Related Genes CAMK2N1 and WNT5A is increased in Locally Invasive and Metastatic Prostate Cancer". Journal of Cancer (2019): http://dx.doi.org/10.7150/jca.34564.
    10.7150/jca.34564
  94. Isabel Armas; Mariana Brandão; Inês Guerreiro; João Lobo; Carla Freitas; João Pinto-de-Sousa; Joaquim Abreu de Sousa. "Incidental diagnosis of breast cancer in the pursuit of the treatment of intestinal obstruction". Autopsy and Case Reports 9 1 (2019): https://doi.org/10.4322%2Facr.2018.071.
    10.4322/acr.2018.071
  95. Suzan Stelloo; Ekaterina Nevedomskaya; Yongsoo Kim; Karianne Schuurman; Eider Valle-Encinas; João Lobo; Oscar Krijgsman; et al. "Integrative epigenetic taxonomy of primary prostate cancer". Nature Communications 9 1 (2018): https://doi.org/10.1038/s41467-018-07270-2.
    10.1038/s41467-018-07270-2
  96. João Lobo; Rui Henrique; Carmen Jeronimo. "The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors". Cancers (2018): http://www.mdpi.com/2072-6694/11/1/6.
    10.3390/cancers11010006
  97. Lobo J; Barros-Silva D; Henrique R; Jerónimo C. "The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors.". Genes (2018): http://europepmc.org/abstract/med/30428628.
    10.3390/genes9110552
  98. Costa AL; Moreira-Barbosa C; Lobo J; Vilela-Salgueiro B; Cantante M; Guimarães R; Lopes P; et al. "DNA methylation profiling as a tool for testicular germ cell tumors subtyping.". Epigenomics (2018): http://europepmc.org/abstract/med/30418048.
    10.2217/epi-2018-0034
  99. Marinho-Dias J; Lobo J; Henrique R; Baldaque I; Pinho-Vaz C; Regadas L; Branca R; et al. "Post-transplant lymphoproliferative disorder in hematopoietic stem cell transplant patients: A single center retrospective study between 2005 and 2012.". Molecular medicine reports (2018): http://europepmc.org/abstract/med/30221663.
    10.3892/mmr.2018.9433
  100. Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; et al. "Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.". Human pathology (2018): http://europepmc.org/abstract/med/30041024.
    10.1016/j.humpath.2018.07.016
  101. Ferreira C; Lobo J; Antunes L; Lopes P; Jerónimo C; Henrique R. "Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features.". Virchows Archiv : an international journal of pathology (2018): http://europepmc.org/abstract/med/30006753.
    10.1007/s00428-018-2406-1
  102. Bárbara Vilela-Salgueiro; Daniela Barros-Silva; João Lobo; Ana Laura Costa; Rita Guimarães; Mariana Cantante; Paula Lopes; et al. "Germ cell tumour subtypes display differential expression of microRNA371a-3p". Philosophical Transactions of the Royal Society B: Biological Sciences 373 1748 (2018): 20170338-20170338. https://doi.org/10.1098/rstb.2017.0338.
    10.1098/rstb.2017.0338
  103. D. Magalhães; C. Costa; I. Furtado; M. J. Matos; A. P. Santos; H. Duarte; M. Afonso; J. Lobo; I. Torres. "Seemingly Harmless Differentiated Thyroid Carcinoma Presenting as Bone Metastasis". Case Reports in Endocrinology (2018): https://doi.org/10.1155/2018/8749075.
    10.1155/2018/8749075
  104. João Lobo; Ângelo Rodrigues; Luís Antunes; Inês Graça; João Ramalho-Carvalho; Filipa Quintela Vieira; Ana Teresa Martins; et al. "High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer". Urologic Oncology: Seminars and Original Investigations 36 4 (2018): 161.e7-161.e17. https://doi.org/10.1016/j.urolonc.2017.10.028.
    10.1016/j.urolonc.2017.10.028
  105. Joana Barbosa; Juliana Faria; Sandra Leal; Luís Pedro Afonso; João Lobo; Odília Queirós; Roxana Moreira; Félix Carvalho; Ricardo Jorge Dinis-Oliveira. "Acute administration of tramadol and tapentadol at effective analgesic and maximum tolerated doses causes hepato- and nephrotoxic effects in Wistar rats". Toxicology (2017): https://doi.org/10.1016%2Fj.tox.2017.07.001.
    10.1016/j.tox.2017.07.001
  106. Juliana Faria; Joana Barbosa; Sandra Leal; Luís Pedro Afonso; João Lobo; Roxana Moreira; Odília Queirós; Félix Carvalho; Ricardo Jorge Dinis-Oliveira. "Effective analgesic doses of tramadol or tapentadol induce brain, lung and heart toxicity in Wistar rats". Toxicology 385 (2017): 38-47. https://doi.org/10.1016%2Fj.tox.2017.05.003.
    10.1016/j.tox.2017.05.003
  107. João Lobo; Rui Henrique; Paula Monteiro; Cláudia Lobo. "ALK-negative anaplastic large cell lymphoma with urinary bladder involvement diagnosed in urine cytology: A case report and literature review". Diagnostic Cytopathology 45 4 (2017): 354-358. https://doi.org/10.1002%2Fdc.23669.
    10.1002/dc.23669
  108. Ana Laura Costa; João Lobo; Carmen Jerónimo; Rui Henrique. "The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers". Epigenomics 9 2 (2017): 155-169. https://doi.org/10.2217%2Fepi-2016-0081.
    10.2217/epi-2016-0081
  109. Sofia Santos-Lopes; João Lobo; Rui Henrique; Jorge Oliveira. "Epididymal metastasis from prostate adenocarcinoma: An unusual and challenging diagnosis suspected in gallium-68 prostate-specific membrane antigen-positron emission tomography/computed tomography and histologically confirmed". Urology Annals 9 1 (2017): 89-89. https://doi.org/10.4103%2F0974-7796.198886.
    10.4103/0974-7796.198886
  110. João Lobo; Bianca Machado; Renata Vieira; Carla Bartosch. "The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor". Virchows Archiv 470 1 (2016): 69-80. https://doi.org/10.1007%2Fs00428-016-2029-3.
    10.1007/s00428-016-2029-3
  111. João Lobo; Carla Pinto; Micaela Freitas; Manuela Pinheiro; Rámon Vizcaino; Esther Oliva; Manuel R. Teixeira; Carmen Jerónimo; Carla Bartosch. "Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?". Virchows Archiv 470 3 (2016): 347-352. https://doi.org/10.1007%2Fs00428-016-2052-4.
    10.1007/s00428-016-2052-4
  112. Rui Henrique; Isa Carneiro; Sara Monteiro-Reis; João Lobo; Ana Luís; Carmen Jerónimo; Ana Martins. "Frozen in Translation: Biobanks as a Tool for Cancer Research". Journal of Intellectual Disability - Diagnosis and Treatment 3 2 (2015): 51-62. https://doi.org/10.6000%2F2292-2598.2015.03.02.2.
    10.6000/2292-2598.2015.03.02.2
Capítulo de livro
  1. João Lobo; Carmen Jerónimo; Rui Henrique. "Targeting chromatin remodelers in urological tumors". 2020.
    10.1016/B978-0-12-816422-8.00008-8
  2. Lobo, João. "Signaling Pathways Involved in Kidney and Urinary Tract Physiology and Pathology". In Tissue-Specific Cell Signaling. Springer, 2020.
    Publicado
  3. "Alpha fetoprotein (AFP)". 2020.
  4. "PLAP". 2020.
  5. "Yolk sac tumor". 2020.
  6. "Tumores da Próstata: Anatomia Patológica". In Manual do Interno de Urologia, Grupo Português Génito-Urinário (GPGU). 2019.
  7. "Tumores do Testículo: Anatomia Patológica". In Manual do Interno de Urologia, Grupo Português Génito-Urinário (GPGU). 2019.
Edição de número de revista
  1. "Tumor Microenvironment of Urogenital Cancers: Looking for Novel Biomarkers and Treatments". Life (2022): https://www.mdpi.com/journal/life/special_issues/TMUC.
  2. "Clinical Advances on the Evaluation and Management of Testicular Germ Cell Tumours". Journal of Clinical Medicine (2022): https://www.mdpi.com/journal/jcm/special_issues/Management_Testicular_Germ_Cell_Tumours.
  3. "Diagnostic and predictive biomarkers in testicular germ cell tumors”". Frontiers in Oncology (2021): https://frontiersin.org/research-topics/28652.
Poster em conferência
  1. Filipa D. dos Reis; Lobo, João; Carneiro, Isa; Freitas, Rui; Henrique, Rui; Jerónimo, Carmen; Correia, Margareta. "Harnessing epigenetic mechanisms to modulate the NK cell-mediated killing of PCa cells". Trabalho apresentado em FCT Encontro Ciência 2024, 2024.
  2. Filipa D. dos Reis; Lobo, João; Carneiro, Isa; Freitas, Rui; Henrique, Rui; Jerónimo, Carmen; Correia, Margareta. "EZH2 inhibition leads to increased NK cell-mediated killing of prostate cancer cells". Trabalho apresentado em III ASPIC-ASEICA International Meeting, 2023.
  3. Monteiro-Reis, Sara; Ferreira, João Pedro; Pires, Ricardo; Lobo, João; Reis, Rui; Natal Jorge, Renato; Jerónimo, Carmen. "Bladder stiffness after cystectomy in male patients: a preliminary study.". Trabalho apresentado em 28th Meeting of the EAU Section of Urological Research, 2022.
  4. Monteiro-Reis, Sara; Ferreira, João Pedro; Pires, Ricardo; Lobo, João; Reis, Rui; Natal Jorge, Renato; Jerónimo, Carmen. "Bladder stiffness after cystectomy in bladder cancer patients: a pilot study.". Trabalho apresentado em 5th ASPIC International congress, 2022.
  5. José Pedro Sequeira; Lobo, João; Constâncio, Vera; Carvalho-Maia, Carina; BRAGA, ISAAC; Maurício, Joaquina; Henrique, Rui; Jerónimo, Carmen. Autor correspondente: Jerónimo, Carmen. "ddPCR: liquid biopsy-based miRNA detection concept in a clinical context". Trabalho apresentado em 16th YES Meeting, CIM - Centro de Investigação Médica, FMUP - Faculdade de Medicina da Universidade do Porto, 2021.
  6. Direito, Inês; Monteiro, Liliana; Melo, Tânia; Figueira, Daniela; Lobo, João; Enes, V.; Moura, Gabriela; et al. "Protein aggregation and hormone-related cancers: a novel approach to improve diagnosis and overcome endocrine therapy resistance?". Trabalho apresentado em Breast Cancer Symposium, 2021.
  7. Cláudia Martins-Lima; Lobo, João; Constâncio, Vera; Catarina Guimarães-Teixeira; Vera Miranda-Gonçalves; Monteiro-Reis, Sara; Ana Lameirinhas; et al. "EMT impact in bladder cancer progression: understanding the cadherins´ role and their regulatory mechanisms". Trabalho apresentado em Porto Cancer Meeting, 2021.
  8. Viveiros, Nicole; Troncarelli Flores, BC; Lobo, João; Martins-Lima, Cláudia; Cantante, Mariana; Lopes, Paula; Henrique, Rui; Jerónimo, Carmen. "Immunoprofiling of bladder cancer: setting the basis for novel immunotherapeutic strategies". Trabalho apresentado em IJUP'21 - 14º Encontro de Investigação Jovem da Universidade do Porto, 2021.
  9. Direito, Inês; Monteiro, Liliana; Enes, V.; Lobo, João; Henrique, Rui; Jerónimo, Carmen; Amado, Francisco; et al. "Breast cancer endocrine resistance is associated to a dysregulation of protein quality control". Trabalho apresentado em EACR-AACR-ASPIC Conference: Tumor Microenvironment, 2020.
  10. Petronilho, S; Sequeira, JP; Paulino, S; Chacim, Sérgio; Lobo, João; Jerónimo, Carmen; Henrique, Rui. Autor correspondente: Henrique, Rui. "Prognostic value of histone modifying enzyme EZH2 and histone mark H3K4me3 in R-CHOP-treated diffuse large B-cell lymphoma". Trabalho apresentado em 32nd Congress of the ESP and XXXIII International Congress of the IAP, 2020.
  11. Guimarães-Teixeira, Catarina; Monteiro-Reis, Sara; Cláudia Martins-Lima; Barros-Silva, Daniela; Lobo, João; Carneiro, Isa; Cantante, Mariana; Henrique, Rui M.F.; Jerónimo, Carmen. "Epitranscriptomic deregulation in bladder cancer: Implications for tumor aggressiveness". Trabalho apresentado em 14th YES Meeting, 2019.
  12. Cláudia Martins-Lima; Monteiro-Reis, Sara; Lobo, João; Guimarães-Teixeira, Catarina; Carneiro, Isa; Cantante, Mariana; Henrique, Rui M.F.; Jerónimo, Carmen. "Diferencial expression of cadherins in Bladder Cancer : Role in epithelial mesenchynal transition". Trabalho apresentado em 14th YES Meeting, 2019.
  13. Cláudia Martins-Lima; Monteiro-Reis, Sara; Lobo, João; Catarina Guimarães-Teixeira; Carneiro, Isa; Cantante, Mariana; Henrique, Rui; Jerónimo, Carmen. "Differential expression of cadherins in bladder cancer: role in epithelial-mesenchymal transition". Trabalho apresentado em 14th YES Meeting, 2019.
  14. Barros-Silva, Daniela; Lobo, João; Guimarães-Teixeira, Catarina; Carneiro, Isa; Oliveira, Jorge; Elena S. Martens-Uzunova; Henrique, Rui M.F.; Jerónimo, Carmen. "Prostate Cancer Epitranscriptome: impact of m6A deregulation in malignancy". Trabalho apresentado em The 3rd International Symposium on Frontiers in Molecular Science - RNA Regulatory Networks, 2019.
  15. Catarina Guimarães-Teixeira; Monteiro-Reis, Sara; Lobo, João; Cláudia Martins-Lima; Carneiro, Isa; Cantante, Mariana; Henrique, Rui; Jerónimo, Carmen. "Epitranscriptiomic deregulation in bladder cancer: Implications for tumor aggressiveness". Trabalho apresentado em 14th YES Meeting, 2019.
  16. Fontes-Sousa, Mário; Lobo, Silvana; Salta, Sofia; Lopes, Paula; Lobo, João; Palma de Sousa, Susana; Henrique, Rui; Jerónimo, Carmen. "Marca Epigénetica H3K27me3 e Risco de Recidiva em Carcinoma da Mama Luminal A/B-like - Epigenetic mark H3K27me3 and Recurrence risk in Luminal A/B-like Breast Carcinoma". Trabalho apresentado em 14th National Oncology Congress, 2017.
  17. Lobo, Silvana; Fontes-Sousa, Mário; Salta, Sofia; Lopes, Paula; Lobo, João; Sousa, Susana; Henrique, Rui; Jerónimo, Carmen. "A Posttranslational Modification In Histones As Prognostic/Predictive Marker In Estrogen-Positive Breast Cancer". Trabalho apresentado em Twelfth YES - Young European Scientist ¿ Meeting, 2017.
Resumo em conferência
  1. "The emerging relevance of RNA modifications in tumor biology: VIRMA contributes to testicular germ cell tumours aggressive phenotype and chemotherapy resistance. Oral Communication. 33rd European Congress of Pathology. Gothenburg, Sweden, August 2021". 2021.
  2. "Combining hypermethylated RASSF1A detection using droplet digital PCR with miR-371a-3p testing: an improved and highly sensitive panel of liquid biopsy biomarkers for testicular germ cell tumour patients. Oral communication. 32nd European Congress of Pathology and XXXIII International Congress of the International Academy of Pathology. Glasgow, Scotland, December 2020". 2020.
  3. "Revisiting a case series of glomangiopericytomas: reassessing STAT6 value in differential diagnosis. Oral communication. 32nd European Congress of Pathology and XXXIII International Congress of the International Academy of Pathology. Glasgow, Scotland, December 2020". 2020.
  4. "Prognostic value of histone modifying enzyme EZH2 and histone mark H3K4me3 in R-CHOP-treated diffuse large B-cell lymphoma. Oral communication. 32nd European Congress of Pathology and XXXIII International Congress of the International Academy of Pathology. Glasgow, Scotland, December 2020". 2020.
  5. "Differential expression of DNA methyltransferases and demethylases among the various subtypes of testicular germ cell tumours. Poster. 32nd European Congress of Pathology and XXXIII International Congress of the International Academy of Pathology. Glasgow, Scotland, December 2020". 2020.
  6. "Designing a model for predicting informative liquid biopsy-based microRNA biomarkers in germ cell tumours: insights from in vitro, in vivo and patient-derived data. Poster. 32nd European Congress of Pathology and XXXIII International Congress of the International Academy of Pathology. Glasgow, Scotland, December 2020". 2020.
  7. "Testicular germ cell tumours: p53/MDM2 expression and association with patient outcome. Poster. 32nd European Congress of Pathology and XXXIII International Congress of the International Academy of Pathology. Glasgow, Scotland, December 2020". 2020.
  8. "Investigation of biomarkers predictive of relapse in stage I testicular germ cell tumour patients on surveillance. Poster. 32nd European Congress of Pathology and XXXIII International Congress of the International Academy of Pathology. Glasgow, Scotland, December 2020". 2020.
  9. "Merkel cell carcinoma metastatic to the testis: report of a rare diagnosis and review of the literature. Poster. 32nd European Congress of Pathology and XXXIII International Congress of the International Academy of Pathology. Glasgow, Scotland, December 2020. Abstract in: Virchows Arch, 2020". 2020.
  10. "Hypermethylated RASSF1A as circulating tumor marker in pediatric and adolescent solid tumors. Poster. AACR Special Conference on Advances in Liquid Biopsies, Miami, USA, Jan 2020". 2020.
  11. "RAD51Bme Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer. Oral Communication. 2020 ASCO Annual Meeting, Chicago, USA, May 2020". 2020.
  12. "Immune infiltrate, immune checkpoints and mismatch repair proteins in testicular germ cell tumors: A role in prognosis and patient outcome. Oral Communication. ESUR Congress 2019, Porto, Portugal, October 2019". 2019.
  13. "Metabolic reprogramming and epigenetic landscape: an interplay to renal cell carcinoma aggressiveness promotion. Oral Communication. ESUR Congress 2019, Porto, Portugal, October 2019". 2019.
  14. "m6A-regulated long non-coding RNAs in prostate cancer. Oral Communication. ESUR Congress 2019, Porto, Portugal, October 2019". 2019.
  15. "Insights into the mechanisms of expression and (specific) secretion of microRNA (-371a-3p) in malignant paediatric and adult germ cell tumours: towards a clinical applicable protocol. Oral Communication. International Extracranial Germ Cell Tumour Conference 2019". 2019.
  16. "Epitranscriptomic deregulation in bladder cancer: Implications for tumor aggressiveness. Poster. 14th YES Meeting. Porto, Portugal, September 2019". 2019.
  17. "Differential expression of cadherins in Bladder Cancer: Role in epithelial mesenchymal transition. Poster. 14th YES Meeting. Porto, Portugal, September 2019". 2019.
  18. "Improvement of vascular invasion scoring in stage I testicular nonseminomas to predict relapse during surveillance after orchiectomy. Oral Communication. 31st European Congress of Pathology. Nice, France, September 2019". 2019.
  19. "Sebaceous carcinoma of the breast in a male patient with a BRCA2 germline mutation: case report and literature review. Poster. 31st European Congress of Pathology. Nice, France, September 2019.". 2019.
  20. "XIST promoter methylation status as putative molecular biomarker for testicular germ cell tumours. Oral Communication. 31st European Congress of Pathology. Nice, France, September 2019". 2019.
  21. "The prognostic value of PD-L1 and CTLA-4 immunoexpression in immune cells and in tumor cells of Testicular Germ Cell Tumors. Poster. 31st European Congress of Pathology. Nice, France, September 2019". 2019.
  22. "Correlative analysis of gene expression changes and PD-L1 immunoexpression in non-small cell lung cancer. Poster. ESMO 2018 Immuno-Oncology Congress. Geneva, Switzerland, December 2018". 2018.
  23. "Diagnostic challenges of testicular sex cord – stromal tumors: A review of 29 cases from two cancer centers. Poster. 10th European Multidisciplinary Congress on Urological Cancers - EMUC 2018". 2018.
  24. "Hematolymphoid testicular tumors: a single-institution clinicopathological characterization of 32 cases. Poster. 10th European Multidisciplinary Congress on Urological Cancers - EMUC 2018". 2018.
  25. "E-cadherin (clone 36) nuclear staining associates with adverse prognostic features in lobular breast carcinoma. Poster. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  26. "Multiple endocrine neoplasia type 2A syndrome with atypical biological behavior – a case report and review of the literature. Poster. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  27. "PD-L1 differential expression among non-small cell lung cancer histologic subtypes and association with EGFR mutational status and ALK/ROS1 rearrangements. Poster. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  28. "Beyond the diagnosis of sinonasal papillomas: a retrospective analysis of 38 cases, with radiological-pathological correlation and literature review. Poster. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  29. "The value of CRIPTO, HOXA9, MGMT, RASSF1A and SCGB3A1 promoter methylation levels for testicular germ-cell tumour subtyping. Poster. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  30. "The challenges of diagnosing testicular germ-cell tumours: revisiting a series of 166 tumours in light of the new WHO classification and AJCC staging system. Poster. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  31. "Primary angiosarcoma of the kidney, epithelioid variant: diagnostic pitfalls and review of the literature. Poster. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  32. "Prognostic value of E-cadherin and P-cadherin immunoexpression in pT3 prostate cancer. Oral Communication. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  33. "Epitranscriptomics in testicular germ-cell tumours: the value of m6A and related proteins for tumour subtyping and prognostication. Oral Communication. 30th European Congress of Pathology. Bilbao, Spain, September 2018". 2018.
  34. "Primary adenocarcinoma of the urinary bladder: next-generation sequencing (NGS) of non-urachal enteric-type adenocarcinomas, urachal adenocarcinomas, mucinous adenocarcinomas, and colonic metaplasias/adenomas. Oral Communication. USCAP 2018 Annual Meeting. Vancouver, Canada, March 2018". 2018.
  35. "The role of Epitranscriptomics in Testicular Germ Cell Tumors biology: m6A RNA modification and its writer/reader VIRMA/YTHDF3. Poster. 9th Copenhagen Workshop on Testicular Germ Cell Cancer, Copenhagen, Denmark, October 2018". 2018.
  36. "Brain metastasis: is the end coming? 20th International Meeting of the European Society of Gynaecological Oncology, Vienna, Austria, November 2017. Poster". 2017.
  37. "A post-translational modification in histones as prognostic/predictive marker in Estrogen-Positive Breast Cancer. Poster. 12th YES Meeting. Porto, Portugal, September 2017". 2017.
  38. "Epigenetic biomarkers in breast cancer: Preliminary results from H3K27m3 assessment in endocrine-treatment resistance. Poster. 42nd ESMO Congress. Madrid, Spain, September 2017". 2017.
  39. "High immunoexpression of EZH2 and SMYD3 in diagnostic prostate biopsies independently predicts outcome in prostate cancer patients. Poster. 29th European Congress of Pathology. Amsterdam, Netherlands, September 2017". 2017.
  40. "Postpubertal teratoma with somatic-type malignancy in the form of Primitive Neuroectodermal Tumor (PNET): a case study with focus on diagnostic pitfalls and the relevance of reporting this tumor subtype. Poster. 29th European Congress of Pathology. Amsterdam, Netherlands, September 2017". 2017.
  41. "Anastomosing hemangioma of the kidney – diagnostic pitfalls and review of the literature. Poster. 29th European Congress of Pathology. Amsterdam, Netherlands, September 2017". 2017.
  42. "Multifocal synchronous bilateral Leydig cell-like testicular tumors in a young patient with clinical suspicion of adrenogenital syndrome and of Ollier disease: just a coincidence? A case study with review of the literature. Poster. 29th European Congress of Pathology. Amsterdam, Netherlands, September 2017". 2017.
  43. "Endometrioid carcinoma with unusual patterns and cell types: a diagnostic challenge. Poster. 29th European Congress of Pathology. Amsterdam, Netherlands, September 2017". 2017.
  44. "Female adnexal tumour of probable Wolffian origin (FATWO): a case report. Poster. 29th European Congress of Pathology. Amsterdam, Netherlands, September 2017". 2017.
  45. "Fine needle aspiration cytology of the kidney correlated with histological data: a 17-year retrospective study. Poster. 29th European Congress of Pathology. Amsterdam, Netherlands, September 2017". 2017.
  46. "Urachal carcinoma: a retrospective analysis of a reference Cancer Center. Poster. 8th European Multidisciplinary Meeting on Urological Cancers. Milan, Italy, November 2016". 2016.
  47. "Diagnostic challenges of metastatic malignancies to the ovary: emphasis on variability of clinical and pathological features. Oral Communication. XXXI International Congress of the IAP and 28th European Congress of Pathology. Cologne, Germany, September 2016". 2016.
  48. "Ovarian uveal melanoma metastasis showing MLH1/PMS2 protein loss in a patient with Lynch Syndrome. Poster. XXXI International Congress of the IAP and 28th European Congress of Pathology. Cologne, Germany, September 2016". 2016.
  49. "Necrotizing acute pancreatitis following trans-arterial chemoembolization of liver metastasis from rectal cancer using irinotecan beads: An autopsy case. Poster. XXXI International Congress of the IAP and 28th European Congress of Pathology. Cologne, Germany, September 2016". 2016.
  50. "Adrenal cortical neoplasms: a review of clinicopathological features of 21 cases from a single institute in light of Weiss criteria. Poster. XXXI International Congress of the IAP and 28th European Congress of Pathology. Cologne, Germany, September 2016". 2016.
  51. "Mucinous tubular and spindle cell carcinoma: morphological heterogeneity and diagnostic pitfalls. Poster. XXXI International Congress of the IAP and 28th European Congress of Pathology. Cologne, Germany, September 2016". 2016.
  52. "Extracapsular Extension and Lymphovascular Invasion in Breast Cancer Sentinel Lymph Nodes Is Associated with Non Sentinel Lymph Node Metastases. Poster. United States and Canadian Academy of Pathology (USCAP) 105th Annual Meeting. Seattle, U.S.A., March 2016". 2016.
  53. "Breast cancer in the neoadjuvant setting: histopathological features that predict treatment response. Oral Communication. 27th European Congress of Pathology. Belgrade, Servia, September 2015". 2015.
  54. "Breast cancer response to neoadjuvant treatment: Adding information with an intermediate biopsy. Oral Communication. 27th European Congress of Pathology. Belgrade, Servia, September 2015". 2015.
Tese / Dissertação
  1. "Uncovering novel prognostic and predictive epigenetic biomarkers in malignant testicular germ cell tumors". Doutoramento, Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, 2021.

Outros

Outra produção
  1. Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium.. 2022. Adriana Fonseca; João Lobo; Florette K Hazard; Joanna Gell; Peter K Nicholls; Robert Weiss; Lindsay Klosterkemper; et al.
    10.17863/cam.89967
  2. Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium.. 2022. Adriana Fonseca; João Lobo; Florette K Hazard; Joanna Gell; Peter K Nicholls; Robert Weiss; Lindsay Klosterkemper; et al.
    10.17863/cam.88609
  3. Refletions on the Recôncavo Series, Brazil. 2018. Renê Luís Moura Antunes; Rui Azevedo; João Lobo.
    10.60692/cd895-zrp22
  4. Refletions on the Recôncavo Series, Brazil. 2018. Renê Luís Moura Antunes; Rui Azevedo; João Lobo.
    10.60692/qw29b-xa049
Atividades

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2022 - Atual Ki67 and LSD1 Expression on Testicular Germ Cell Tumors: correlation with pathological and clinical features
Coorientador
 Mestrado Integrado em Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019 - 2020 p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: association with clinical outcome
Coorientador
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019 - 2019 Biomarkers in TGCTs
Coorientador
 Master in Biology (Mestrado)
Prinses Máxima Centrum voor Kinderoncologie, Países Baixos

Universitair Medisch Centrum Utrecht, Países Baixos
2017 - 2018 Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features
Coorientador
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2021 - Atual European Cancer Research Summit (participação na organização) (2021) Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Participação em evento

Descrição da atividade
Tipo de evento 		Nome do evento
Instituição / Organização
2021 - Atual Invited speaker: The heterogeneity of Prostate Cancer: morphology, genetics and epigenetics. Clinical Sessions: Genetic Considerations in Urological Tumors ¿ Prostate Cancer ¿ Lisbon, Portugal, February 2021 Clinical Sessions: Genetic Considerations in Urological Tumors – Prostate Cancer
2021 - Atual Invited Speaker: Congresso da Associação Portuguesa de Urologia - Testicular Cancer and Reference Centers - New Biomarkers, What is the future? Congresso Nacional da Associação Portuguesa de Urologia. Lisboa, Portugal, Novembro de 2021 Congresso da Associação Portuguesa de Urologia
2019 - Atual Invited Speaker: The genvironment and the major role of epigenetics in human germ cell tumours: looking for disease biomarkers and novel treatment options. Oral Communication. 26th Porto Cancer Meeting 2019 & 5th Porto-Bordeaux Joint Meeting
Congresso
 26th Porto Cancer Meeting 2019 & 5th Porto-Bordeaux Joint Meeting

Júri de grau académico

Tema
Tipo de participação 		Nome do candidato (Tipo de grau)
Instituição / Organização
2022/03/24 Epigenetic biomarkers in bladder cancer
Arguente principal
 Francisca Nunes (Mestrado)
Universidade de Coimbra Faculdade de Medicina, Portugal

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2022 - Atual Life Academic Editor of a Research Topic on Urological Tumors
2022 - Atual Journal of Clinical Medicine Academic Editor of a Research Topic on Testicular Germ Cell Tumors
2021 - Atual Frontiers in Oncology Academic Editor of a Research Topic on Testicular Germ Cell Tumors
2015 - Atual Peer review of 81 manuscripts

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2021/11 - Atual Técnicas Laboratoriais em Biopatologia (Mestrado) Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2020 - Atual Formação Avançada Pós-Universitária em Oncologia, Liga Portuguesa Contra o Cancro – Núcleo Regional do Norte, Portugal Biopatologia Oncológica (Pós-Graduação) Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2020 - Atual Curso de Introdução à Investigação Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2017 - Atual Mestrado em Macroscopia em Anatomia Patológica Macroscopia em Anatomia Patológica (Especialização pós-licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2016 - Atual Mestrado em Oncologia Oncologia (Mestrado) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - Atual Anatomia Patológica (aula prática) Patologia e Genética Molecular (Doutoramento) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015 - Atual Anatomia Patológica - Mestrado Integrado em Bioquímica Bioquímica (Mestrado integrado) Universidade do Porto Faculdade de Ciências, Portugal

Entrevista (jornal / revista)

Descrição da atividade Jornal / Forum
2022 https://ipoporto.pt/jovem-investigador-recebe-premio-life-2021-young-investigator/?fbclid=IwAR2BMjpLcJrNUa3Wwu1w7e16g4HbFaABt-v5F5DYOec94o06zgRLphv9-SQ
2022 Entrevista - orador convidado no Congresso da Associação Portuguesa de Urologia (APU) - 12. https://apurologia.pt/jornal/CAPU2021_D2.pdf Urologia Actual
2021 https://sicnoticias.pt/tenho-cancro-e-depois/e-depois/os-especialistas/2021-02-15-Cancro-infantil.-Temos-que-pensar-em-como-os-tratamentos-podem-vir-a-ter-impacto-na-qualidade-de-vida-destes-que-sao-os-adultos-do-futuro
2021 https://www.pipop.info/a-populacao-pediatrica-com-este-tipo-de-tumores-tem-sido-um-pouco-esquecida-defende-joao-pedro-lobo-vencedor-do-premio-rui-osorio-de-castro-millennium-bcp/?fbclid=IwAR0duXDi8RkS2eNRUF02qKw8jaq0vjuY4sK0VL1T52Hhh4M4NU5rKaQ6Cdw
2021 https://www.pipop.info/explorar-a-investigacao-em-portugal-o-projeto-vencedor-da-5a-edicao-do-premio-rui-osorio-de-castro-millennium-bcp/
2021 Paper highlighted in social media
2020 https://noticias.up.pt/estudante-do-icbas-vence-premio-msd-de-investigacao-em-saude-2020/?fbclid=IwAR1pUitINlaFaRkDE5ZDz1I8iLrzxVrfADrLCXRyay15jX-NWuERavRH14g
2020 https://noticias.up.pt/investigador-da-u-porto-vence-premio-da-ordem-dos-medicos/
2020 Interview for “Norte Médico”, Revista da Secção Regional do Norte da Ordem dos Médicos (Oct-Dec 2020, ISSN 0874-7431) Norte Médico”, Revista da Secção Regional do Norte da Ordem dos Médicos
2020 Paper highlighted in social media
2020 Paper highlighted in social media
2020 Paper highlighted in social media
2020 Paper highlighted in social media
2019 https://research.prinsesmaximacentrum.nl/en/news-events/news/maxima-researcher-joao-lobo-receives-tom-voute-investigator-award
2019 https://www.kika.nl/actueel/tom-voute-young-investigator-awards-2019?utm_source=e-mail&utm_medium=clang&utm_campaign=Nieuwsbrief_191128&utm_content=399
2019 Paper highlighted in social media
2019 Paper highlighted in social media
2018 Paper highlighted in social media
2018 Paper highlighted in social media
2018 Paper highlighted in social media
2017 Paper highlighted in social media
2017 Paper highlighted in social media

Expedição científica

Descrição da atividade Instituição / Organização
2021 - Atual Fellowship in Uropathology at the University Hospital Zurich (USZ), under supervision of Prof. Holger Moch, 2021 (funded by Liga Portuguesa Contra o Cancro Núcleo Regional do Norte) UniversitätsSpital Zürich Institut für klinische Pathologie, Suiça
2019 - Atual Internship in Molecular Pathology at the University Medical Center Utrecht (UMCU) – 2019 Universiteit Utrecht, Países Baixos

Membro de associação

Nome da associação Tipo de participação
2023 - Atual EAU Section of Uropathology (ESUP) Board member
2023 - Atual Young Cancer Professionals (YCP) – European Cancer Organization - https://www.europeancancer.org/2-standard/530-young-cancer-professionals Member
2022 - Atual Portuguese Association of Research in Cancer (ASPIC): membership number ASPIC487 Membro da Direção: Alternate voting member, years 2022-2023
2021 - Atual Malignant Germ Cell International Consortium (MaGIC) Member of "Pathology Committee" and Vice-Chair of "Young Investigators Committee"
2021 - Atual Genitourinary Pathology Society (GUPS): membership number 58996790
2021 - Atual European Association of Urology (EAU): membership number EAU-117582
2021 - Atual Young Academic Urologists (YAU) - Member of Penile & Testis Working Group - https://uroweb.org/offices/yau-working-group-penile-testis-cancer Active member
2018 - Atual Portuguese Association of Research in Cancer (ASPIC): membership number ASPIC487
2018 - Atual European Association for Cancer Research (EACR): membership number EACR29544
2015 - Atual European Society of Pathology (ESP): membership number 9769
2015 - Atual European Society of Pathology (ESP): membership number 9769 Member of Uropathology Working Group, of Molecular Pathology Working Group and of the Alumni Program

Outro júri / avaliação

Descrição da atividade Instituição / Organização
2019 - Atual Evaluation of a research proposal on gynecological cancer Prinses Máxima Centrum voor Kinderoncologie, Países Baixos

Tutoria

Tópico Nome do aluno
2021 - Atual Anatomia Patológica Helena Pereira
2017 - Atual Anatomia Patológica Roxana Sav
2017 - Atual Anatomia Patológica Joana Cunha
2016 - Atual Anatomia Patológica Catarina Dias
2015 - Atual Anatomia Patológica Alina Rosinha
Distinções

Prémio

2023 International Society of Urological Pathology (ISUP) Stipend Award (500$)
2023 Honorable Mention for the Category “Histopathology Posters”
2023 ESP Bursary Award for the 35th European Congress of Pathology (250 Euro)
2023 Prémio Banco Carregosa / Secção Regional do Norte da Ordem dos Médicos (SRNOM), 6th Edition (Honorable Mention; 2,500 Euro)
2023 “Bolsa de Investigação Clínica CUF – D. Manuel Mello” (Honorable Mention)
2022 Cancers 2022 PhD Thesis Award
2021 Prize "Rui Osório de Castro / Millennium bcp, 5th Edition", 15,000€
Fundação Rui Osório de Castro / Millennium bcp, Portugal
2021 ESP Bursary Award for the 32rd European Congress of Pathology
European Society of Pathology, Bélgica
2021 Life 2021 Young Investigator Award
2020 Prémio Banco Carregosa / Secção Regional do Norte da Ordem dos Médicos (SRNOM), 4th Edition (Honorable Mention; 2,500 Euro)
Ordem dos Médicos, Portugal

Banco Carregosa, Portugal
2020 MSD Award for Research in Health, 2nd Edition (10,000 Euro)
Merck Sharp and Dohme, Austrália
2020 ESP Bursary Award for the XXXIII International Congress of the IAP and 32nd European Congress of Pathology
European Society of Pathology, Bélgica
2019 Tom Voute Award 2019
Stichting Kinderen Kankervrij, Países Baixos
2019 ECP 2nd Best Oral Communication
European Society of Pathology, Bélgica
2019 ESP Bursary Award for the 31st European Congress of Pathology (150 Euro)
European Society of Pathology, Bélgica
2018 3ª melhor média de conclusão do Mestrado Integrado em Medicina
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018 ESP Bursary Award for the 30th European Congress of Pathology (150 Euro)
European Society of Pathology, Bélgica
2018 ESP Academy Bursary for attending the 1st European Society of Pathology Academy
European Society of Pathology, Bélgica
2017 ESP Bursary Award for the 29th European Congress of Pathology (150 Euro)
European Society of Pathology, Bélgica
2016 ESP Bursary Award for the XXXI International Congress of the IAP and 28th European Congress of Pathology (150 Euro and accommodation)
European Society of Pathology, Bélgica
2015 ESP Bursary Award for the 27th European Congress of Pathology (150 Euro)
European Society of Pathology, Bélgica
2008 Prémio Professor Armando Moreno
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2007 Melhor aluno do ensino secundário (média final: 20)
Escola Secundária José Macedo Fragateiro, Portugal
2004 Melhor aluno do 3º ciclo
E.B.2,3 António Dias Simões, Portugal
2001 Melhor aluno do 2º ciclo
E.B.2,3 António Dias Simões, Portugal

Outra distinção

2021 Positive commentary (Editorial) to article on testicular germ cell tumors
2019 Article selected for Cover Art of Modern Pathology Journal
2019 Positive commentary (Editorial) to article on testicular germ cell tumors
2018 ITC Conference Grant EPITRAN COST Action 1,300Eur
European Cooperation in Science and Technology, Bélgica
2017 OECI Bursary Award for 7th EACR-OECI Joint Training Course
European Association For Cancer Research, Reino Unido
2017 OECI Bursary Award for 2nd EACR-OECI Conference
European Association For Cancer Research, Reino Unido
2011 Winner of Contest "Ágora Medicina"
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal